271. Ankylosing spondylitis Clinical trials / Disease details
Clinical trials : 563 / Drugs : 372 - (DrugBank : 72) / Drug target genes : 41 - Drug target pathways : 145
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04135508 (ClinicalTrials.gov) | December 13, 2016 | 17/10/2019 | A Phase III Study Evaluate the Efficacy and Safety of BAT1406 and Humira | A Multicenter, Randomized, Double-Blind, Phase III Clinical Trial Parallel Controlled With Humira to Evaluate the Efficacy and Safety of BAT1406 Injection in the Treatment of Ankylosing Spondylitis | Ankylosing Spondylitis | Drug: BAT1406;Drug: Humira | Bio-Thera Solutions | NULL | Completed | 16 Years | 65 Years | All | 554 | Phase 3 | NULL |